Delivery Order SPE2DB20D3103-SPE2DB25FP8V0
- Not listed
- The Defense Logistics Agency awarded a $1,577.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexmedetomidine 200 MCG/2 ML in 2 ML vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the company's broader pharmaceutical supply portfolio...
- The U.S. federal government awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of the drug Dexmedetomidine 400mcg/100ml-NS 100ml. The $2,167.80 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which manages logistics and acquisition for the Department of Defense (DoD). This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The contract has a ceiling value of $1,708.81 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency awarded a $4,563.76 firm fixed price delivery order to Amerisourcebergen Drug Corp for 200 mcg/2ml dexmedetomidine in 2ml vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver the product to a location in Conshohocken, Pennsylvania under a period of performance from August 17-18, 2023. The Defense Logistics Agency facilitates procurement for the Department of Defense to support its global supply chain needs, and this delivery order is likely...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $225,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561919757 DEXMEDETOMIDINE 200 MCG/2 ML 2ML. The single day contract runs from August 23 to August 24, 2023 for product delivery to a location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. No additional subcontractors or set aside designations were...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the medical product DEXMEDETOMIDINE 200 MCG/2 ML 2ML, with a ceiling value of $5,201.97 and a completion date of November 15, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,026.56 award is for the delivery of a pharmaceutical product, Dexmedetomidin 400mcg/100ml-NS 100ml, with a completion date of February 6, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- This is a $4,206.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mcg/100 mL dexmedetomidine saline solution. The order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Dexmedetomidine 400 mcg/100 mL-NS 100 mL, a critical care medication. The $1,013.28 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for the delivery of a comprehensive range of medical commodities to support military...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8V0Delivery Order
The Defense Logistics Agency awarded a $18,937.75 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dexmedetomidine 200 mcg/2 mL vials. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. Performance will be completed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other government agencies. The company's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for dexmedetomidine, a sedative and analgesic agent used in clinical and military medical settings, exemplifies the company's role in supporting the Defense Health Agency and broader Department of Defense healthcare requirements through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 8/14/25 |